U.S. orphan designations granted to atezolizumab, atezolizumab plus cobimetinib for melanoma Feb. 17, 2017
Merck Sharp & Dohme begins phase I testing of MK-1454 in advanced solid tumors, lymphomas Feb. 13, 2017
Seattle Genetics and Immunomedics enter global license agreement for sacituzumab govitecan Feb. 13, 2017
Boehringer Ingelheim starts phase II trial to treat advanced squamous cell carcinoma of the lung Feb. 10, 2017
RSS